Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg H Waetzig

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 8, 2014
Interleukin-6: a villain in the drama of pancreatic cancer development and progressionReinhild Holmer, Freya A Goumas, Georg H Waetzig, et al.
Biochemical and Biophysical Research Communications|January 26, 2016
A soluble form of the interleukin-6 family signal transducer gp130 is dimerized via a C-terminal disulfide bridge resulting from alternative mRNA splicingJanina Wolf, Georg H Waetzig, Torsten M Reinheimer, et al.
Gastroenterology|April 3, 2003
TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cellsPhilip Rosenstiel, Massimo Fantini, Karen Bräutigam, et al.
The Journal of Biological Chemistry|May 27, 2016
Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signalingJanina Wolf, Georg H Waetzig, Athena Chalaris, et al.
The Journal of Biological Chemistry|July 25, 2008
Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130Stephanie Tenhumberg, Georg H Waetzig, Athena Chalaris, et al.
Plos One|May 5, 2020
Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cellsJuliane Lokau, Florian Kleinegger, Yvonne Garbers, et al.
Immunobiology|March 6, 2012
Therapeutic targeting of interleukin-6 trans-signaling does not affect the outcome of experimental tuberculosisJan Sodenkamp, Georg H Waetzig, Jürgen Scheller, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 30, 2004
Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1Georg H Waetzig, Philip Rosenstiel, Alexander Arlt, et al.
Biochimica Et Biophysica Acta|December 7, 2010
Essential role of neutrophil mobilization in concanavalin A-induced hepatitis is based on classic IL-6 signaling but not on IL-6 trans-signalingSven Malchow, Wolfgang Thaiss, Nathalie Jänner, et al.
Science Signaling|October 4, 2018
Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responsesLarissa Lamertz, Franziska Rummel, Robin Polz, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 8, 2014
Interleukin-6: a villain in the drama of pancreatic cancer development and progressionReinhild Holmer, Freya A Goumas, Georg H Waetzig, et al.
Biochemical and Biophysical Research Communications|January 26, 2016
A soluble form of the interleukin-6 family signal transducer gp130 is dimerized via a C-terminal disulfide bridge resulting from alternative mRNA splicingJanina Wolf, Georg H Waetzig, Torsten M Reinheimer, et al.
Gastroenterology|April 3, 2003
TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cellsPhilip Rosenstiel, Massimo Fantini, Karen Bräutigam, et al.
The Journal of Biological Chemistry|May 27, 2016
Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signalingJanina Wolf, Georg H Waetzig, Athena Chalaris, et al.
The Journal of Biological Chemistry|July 25, 2008
Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130Stephanie Tenhumberg, Georg H Waetzig, Athena Chalaris, et al.
Plos One|May 5, 2020
Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cellsJuliane Lokau, Florian Kleinegger, Yvonne Garbers, et al.
Immunobiology|March 6, 2012
Therapeutic targeting of interleukin-6 trans-signaling does not affect the outcome of experimental tuberculosisJan Sodenkamp, Georg H Waetzig, Jürgen Scheller, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 30, 2004
Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1Georg H Waetzig, Philip Rosenstiel, Alexander Arlt, et al.
Biochimica Et Biophysica Acta|December 7, 2010
Essential role of neutrophil mobilization in concanavalin A-induced hepatitis is based on classic IL-6 signaling but not on IL-6 trans-signalingSven Malchow, Wolfgang Thaiss, Nathalie Jänner, et al.
Science Signaling|October 4, 2018
Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responsesLarissa Lamertz, Franziska Rummel, Robin Polz, et al.
Pageof 6